期刊文献+

Toll样受体3在原发性肝细胞癌中的表达及其与细胞凋亡、血管生成的相关性 被引量:3

Expression of toll like receptor 3 and its correlation with cell apoptosis and angiogenesis in hepatocellular carcinoma
原文传递
导出
摘要 目的探讨Toll样受体3(TLR3)在原发性肝细胞癌(HCC)中的表达及其与细胞凋亡、血管生成的相关性。方法采用免疫组化检测85例HCC患者TLR3的表达,同时检测凋亡相关蛋白和血管生成相关指标,TUNEL法检测HCC细胞凋亡情况。结果 HCC中,TLR3阳性表达率为58.8%(50/85),TLR3的表达与生存素和Bcl-2呈负相关(P<0.01),与Caspase-3、Caspase-8和Caspase-9呈正相关(P<0.05或P<0.01)。TLR3的表达与凋亡指数呈正相关(P<0.01),与MMP-2、微血管密度和内皮干细胞计数呈负相关(P<0.01)。结论 HCC中TLR3的表达与细胞凋亡及血管生成有关,提示TLR3参与HCC的发生、发展。 Objective To investigate the expression of toll like receptor 3(TLR3)and its correlation with cell apoptosis and angiogenesis in hepatocellular carcinoma(HCC).Methods The expression of TLR3 was detected by immunohistochemistry in 85 cases with HCC.The expressions of apoptosis-related and angiogenesis-related proteins were detected as well.The cell apoptosis was evaluated by TUNEL assay.Results The positive rate of TLR3 in HCC was 58.8%,which was negatively correlated with survivin,Bcl-2,MMP-2,microvessel density and endothelial stem cell count,and positively correlated with Caspase-3,Caspase-8,Caspase-9 and apoptotic index(P〈0.05 or P〈0.01).Conclusion The expression of TLR3 in HCC is related to cell apoptosis and angiogenesis,which may play a role in the development of HCC.
作者 袁明明 任晓燕 谢慧君 王伟伟 陈莉 YUAN Mingming , REN Xiaoyan , XIE Huijun , et al(Department of Pathology , Nantong Maternity and Child Care Hospital, Nantong 226006, CHIN)
出处 《江苏医药》 CAS 2018年第3期256-259,F0003,共5页 Jiangsu Medical Journal
基金 南通市卫生和计划生育委员会青年科研基金项目(WQ2016103)
关键词 TOLL样受体3 原发性肝细胞癌 细胞凋亡 血管生成 Toll like receptor 3 Hepatocellular carcinoma Cell apoptosis Angiogenesis
  • 相关文献

参考文献2

二级参考文献17

  • 1嵇武,李宁.Toll样受体与临床疾病关系的研究进展[J].中国误诊学杂志,2007,7(16):3709-3711. 被引量:7
  • 2Parker LC,Pr ince LR,Sabroe I.Translational mini-reviewSeries on Toll-like receptors:networks regulated by Toll-likereceptors mediate innate and adaptive immunity[J].Clin ExpImmunol,2007,147(2):199-207.
  • 3Engel AL,Holt GE,Lu H.The pharmacokinetics of Toll-likereceptor agonists and the impact on the immune system[J].Expert Rev Clin Pharmacol,2011,4(2):275-289.
  • 4Zeromski J,Mozer-Lisewska I,Kaczmarek M.Significance oftoll-like receptors expression in tumor growth and spreading:a short review[J].Cancer Microenviron,2008,1(1):37-42.
  • 5Michelsen KS,Arditi M.Toll-like receptors and innateimmunity in gut homeost asis and pathology[J].Curr OpinHematol,2007,14(1):48-54.
  • 6Zapata JM,Llobet D,Krajewska M,et al.Lymphocyte-specificTRAF3transgenic mice have enhanced humoral responsesand develop plasmacytosis,autoimmunity,inflammation,andcancer[J].Blood,2009,113(19):4595-4603.
  • 7Sado T,Naruse K,Noguchi T,et al.Inflammatory patternrecognition receptors and their ligands:factors contributing tothe pathogenesis of preeclampsia[J].Inflamm Res,2011,60(6):509-520.
  • 8Valins W,Amini S,Berman B.The expression of Toll-likereceptors in dermatological diseases and the therapeutic effectof current and newer topical Toll-like receptor modulators[J].J Clin Aesthet Dermatol,2010,3(9):20-29.
  • 9Kanzler H,Barrat FJ,Hessel EM,et al.Therapeutic targe-ting of innate immunity with Toll-like receptor agonists andantagonists[J].Nat Med,2007,13(5):552-559.
  • 10Hoption Cann S,van Netten JP,vail Netten C.Dr williamcoley and tumour regression:aplace in history or in the future[J].Postgraduate Medical Journal,2003,79(938):672-680.

共引文献13

同被引文献21

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部